{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:56:36Z","timestamp":1791294996086,"version":"4.1.0"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Signals mediated by the chemokine CXCL12 and its receptor CXCR4 are involved in the progression of ovarian cancer through enhancement of tumor angiogenesis and immunosuppressive networks that regulate dissemination of peritoneal metastasis and development of cancer-initiating cells (CICs). In this study, we investigated the antitumor efficacy of a CXCR4 antagonist expressed by oncolytic vaccinia virus (OVV) against an invasive variant of the murine epithelial ovarian cancer cell line ID8-T. This variant harbors a high frequency of CICs that form multilayered spheroid cells and express the hyaluronan receptor CD44, as well as stem cell factor receptor CD117 (c-kit). Using an orthotopic ID8-T tumor model, we observed that i.p. delivery of a CXCR4 antagonist\u2013expressing OVV led to reduced metastatic spread of tumors and improved overall survival compared with oncolysis alone. Inhibition of tumor growth with the armed virus was associated with efficient killing of CICs, reduced expression of ascitic CXCL12 and vascular endothelial growth factor, and decreases in i.p. numbers of endothelial and myeloid cells, as well as plasmacytoid dendritic cells. These changes, together with reduced recruitment of T regulatory cells, were associated with higher ratios of IFN-\u03b3+\/IL-10+ tumor-infiltrating T lymphocytes, as well as induction of spontaneous humoral and cellular antitumor responses. Similarly, the CXCR4 antagonist released from virally infected human CAOV2 ovarian carcinoma cells inhibited peritoneal dissemination of tumors in SCID mice, leading to improved tumor-free survival in a xenograft model. Our findings demonstrate that OVV armed with a CXCR4 antagonist represents a potent therapy for ovarian CICs with a broad antitumor repertoire.<\/jats:p>","DOI":"10.4049\/jimmunol.1400201","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T01:07:29Z","timestamp":1413421649000},"page":"5327-5337","source":"Crossref","is-referenced-by-count":134,"title":["CXCL12\/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells"],"prefix":"10.1093","volume":"193","author":[{"given":"Margaret","family":"Gil","sequence":"first","affiliation":[{"name":"Department of Immunology, Roswell Park Cancer Institute , Buffalo, NY 14263"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin P","family":"Komorowski","sequence":"additional","affiliation":[{"name":"Department of Immunology, Roswell Park Cancer Institute , Buffalo, NY 14263"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukund","family":"Seshadri","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute , Buffalo, NY 14263"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Rokita","sequence":"additional","affiliation":[{"name":"Faculty of Biochemistry, Biophysics, and Biotechnology, Jagiellonian University , 30-387 Krakow ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J Robert","family":"McGray","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Roswell Park Cancer Institute , Buffalo, NY 14263"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Opyrchal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Roswell Park Cancer Institute , Buffalo, NY 14263"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunle O","family":"Odunsi","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Roswell Park Cancer Institute , Buffalo, NY 14263"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta","family":"Kozbor","sequence":"additional","affiliation":[{"name":"Department of Immunology, Roswell Park Cancer Institute , Buffalo, NY 14263"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,11,15]]},"reference":[{"key":"2025030707445356100_r1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J. Clin."},{"key":"2025030707445356100_r2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ijc.23083","article-title":"Involvement of SDF-1alpha\/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma","volume":"122","author":"Kajiyama","year":"2008","journal-title":"Int. J. Cancer"},{"key":"2025030707445356100_r3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12026-009-8100-2","article-title":"Omental immune aggregates and tumor metastasis within the peritoneal cavity","volume":"45","author":"Sorensen","year":"2009","journal-title":"Immunol. Res."},{"key":"2025030707445356100_r4","first-page":"675","article-title":"Update on treatment options for newly diagnosed ovarian cancer","volume":"8","author":"Armstrong","year":"2010","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"2025030707445356100_r5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ygyno.2013.12.001","article-title":"Ovarian cancer stem cells: are they real and why are they important?","volume":"132","author":"Shah","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"2025030707445356100_r6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.canlet.2012.10.023","article-title":"Ovarian cancer stem cells: working towards the root of stemness","volume":"338","author":"Foster","year":"2013","journal-title":"Cancer Lett."},{"key":"2025030707445356100_r7","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1158\/0008-5472.CAN-04-3931","article-title":"Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer","volume":"65","author":"Bapat","year":"2005","journal-title":"Cancer Res."},{"key":"2025030707445356100_r8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ijc.25967","article-title":"Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells","volume":"130","author":"Kryczek","year":"2012","journal-title":"Int. J. Cancer"},{"key":"2025030707445356100_r9","doi-asserted-by":"crossref","first-page":"620523","DOI":"10.1155\/2011\/620523","article-title":"Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer","volume":"2011","author":"Steffensen","year":"2011","journal-title":"J. Oncol."},{"key":"2025030707445356100_r10","doi-asserted-by":"crossref","first-page":"916819","DOI":"10.1155\/2013\/916819","article-title":"Ovarian cancer stem cells: a new target for cancer therapy","volume":"2013","author":"Zhan","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"2025030707445356100_r11","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","article-title":"Identification and characterization of ovarian cancer-initiating cells from primary human tumors","volume":"68","author":"Zhang","year":"2008","journal-title":"Cancer Res."},{"key":"2025030707445356100_r12","doi-asserted-by":"crossref","first-page":"e84941","DOI":"10.1371\/journal.pone.0084941","article-title":"Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism","volume":"9","author":"Liao","year":"2014","journal-title":"PLoS ONE"},{"key":"2025030707445356100_r13","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","article-title":"Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer","volume":"102","author":"Sato","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030707445356100_r14","doi-asserted-by":"crossref","first-page":"12837","DOI":"10.1073\/pnas.0703342104","article-title":"Vaccination with an NY-ESO-1 peptide of HLA class I\/II specificities induces integrated humoral and T cell responses in ovarian cancer","volume":"104","author":"Odunsi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030707445356100_r15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2011.09.039","article-title":"Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis","volume":"124","author":"Hwang","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"2025030707445356100_r16","first-page":"1347","article-title":"Emerging targets in cancer management: role of the CXCL12\/CXCR4 axis","volume":"6","author":"Cojoc","year":"2013","journal-title":"Onco. Targets Ther."},{"key":"2025030707445356100_r17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/BF03349262","article-title":"The critical role of SDF-1\/CXCR4 axis in cancer and cancer stem cells metastasis","volume":"31","author":"Gelmini","year":"2008","journal-title":"J. Endocrinol. Invest."},{"key":"2025030707445356100_r18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","article-title":"Cancer stem cells in solid tumours: accumulating evidence and unresolved questions","volume":"8","author":"Visvader","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"2025030707445356100_r19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1634\/stemcells.2004-0342","article-title":"Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis","volume":"23","author":"Kucia","year":"2005","journal-title":"Stem Cells"},{"key":"2025030707445356100_r20","first-page":"5930","article-title":"Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer","volume":"62","author":"Scotton","year":"2002","journal-title":"Cancer Res."},{"key":"2025030707445356100_r21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1158\/0008-5472.465.65.2","article-title":"CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers","volume":"65","author":"Kryczek","year":"2005","journal-title":"Cancer Res."},{"key":"2025030707445356100_r22","doi-asserted-by":"crossref","first-page":"C987","DOI":"10.1152\/ajpcell.00406.2006","article-title":"Stroma-derived factor (SDF-1\/CXCL12) and human tumor pathogenesis","volume":"292","author":"Kryczek","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2025030707445356100_r23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"2025030707445356100_r24","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1158\/0008-5472.CAN-11-2449","article-title":"PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment","volume":"71","author":"Obermajer","year":"2011","journal-title":"Cancer Res."},{"key":"2025030707445356100_r25","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/nm1201-1339","article-title":"Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells","volume":"7","author":"Zou","year":"2001","journal-title":"Nat. Med."},{"key":"2025030707445356100_r26","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1158\/0008-5472.CAN-10-3143","article-title":"CXCL12\/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer","volume":"71","author":"Righi","year":"2011","journal-title":"Cancer Res."},{"key":"2025030707445356100_r27","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"2025030707445356100_r28","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1200\/JCO.2004.07.131","article-title":"Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin\u2019s lymphoma","volume":"22","author":"Devine","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"2025030707445356100_r29","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1158\/1078-0432.CCR-07-4846","article-title":"Translating an Antagonist of Chemokine Receptor CXCR4: from bench to bedside","volume":"14","author":"Wong","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"2025030707445356100_r30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ijc.25665","article-title":"CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model","volume":"129","author":"Hassan","year":"2011","journal-title":"Int. J. Cancer"},{"key":"2025030707445356100_r31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jss.2008.06.044","article-title":"A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer","volume":"155","author":"Huang","year":"2009","journal-title":"J. Surg. Res."},{"key":"2025030707445356100_r32","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.4049\/jimmunol.163.5.2368","article-title":"Cutting edge: CXCR4-Lo: molecular cloning and functional expression of a novel human CXCR4 splice variant","volume":"163","author":"Gupta","year":"1999","journal-title":"J. Immunol."},{"key":"2025030707445356100_r33","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","article-title":"CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment","volume":"107","author":"Burger","year":"2006","journal-title":"Blood"},{"key":"2025030707445356100_r34","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.20041385","article-title":"Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist","volume":"201","author":"Broxmeyer","year":"2005","journal-title":"J. Exp. Med."},{"key":"2025030707445356100_r35","doi-asserted-by":"crossref","first-page":"E1291","DOI":"10.1073\/pnas.1220580110","article-title":"Targeting CXCL12\/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases","volume":"110","author":"Gil","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030707445356100_r36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrc2545","article-title":"Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer","volume":"9","author":"Kirn","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"2025030707445356100_r37","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/mt.2011.276","article-title":"The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers","volume":"20","author":"Parato","year":"2012","journal-title":"Mol. Ther."},{"key":"2025030707445356100_r38","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1073\/pnas.95.13.7544","article-title":"Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope","volume":"95","author":"Vanderplasschen","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030707445356100_r39","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ni1059","article-title":"Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance","volume":"5","author":"Yang","year":"2004","journal-title":"Nat. Immunol."},{"key":"2025030707445356100_r40","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood-2006-06-027136","article-title":"Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta","volume":"109","author":"Zhu","year":"2007","journal-title":"Blood"},{"key":"2025030707445356100_r41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1479-5876-10-167","article-title":"Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells","volume":"10","author":"Wang","year":"2012","journal-title":"J. Transl. Med."},{"key":"2025030707445356100_r42","first-page":"2785","article-title":"Comparison of ID8 MOSE and VEGF-modified ID8 cell lines in an immunocompetent animal model for human ovarian cancer","volume":"26","author":"Jan\u00e1t-Amsbury","year":"2006","journal-title":"Anticancer Res."},{"key":"2025030707445356100_r43","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1038\/onc.2010.288","article-title":"The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells","volume":"29","author":"Goncharenko-Khaider","year":"2010","journal-title":"Oncogene"},{"key":"2025030707445356100_r44","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/j.1460-2075.1986.tb04496.x","article-title":"Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes","volume":"5","author":"Schneider-G\u00e4dicke","year":"1986","journal-title":"EMBO J."},{"key":"2025030707445356100_r45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1073\/pnas.52.1.53","article-title":"Infection of Human and Simian Tissue Cultures with Rous Sarcoma Virus","volume":"52","author":"Jensen","year":"1964","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030707445356100_r46","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2144\/97236st07","article-title":"Compact, synthetic, vaccinia virus early\/late promoter for protein expression","volume":"23","author":"Chakrabarti","year":"1997","journal-title":"Biotechniques"},{"key":"2025030707445356100_r47","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/bjc.2011.429","article-title":"Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice","volume":"105","author":"Gil","year":"2011","journal-title":"Br. J. Cancer"},{"key":"2025030707445356100_r48","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.4049\/jimmunol.0900364","article-title":"Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice","volume":"183","author":"Gil","year":"2009","journal-title":"J. Immunol."},{"key":"2025030707445356100_r49","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.bbrc.2007.05.182","article-title":"CXCR4\/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway","volume":"359","author":"Liang","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2025030707445356100_r50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1634\/theoncologist.9-suppl_1-2","article-title":"Vascular endothelial growth factor as a target for anticancer therapy","volume":"9","author":"Ferrara","year":"2004","journal-title":"Oncologist"},{"key":"2025030707445356100_r51","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr. Rev."},{"key":"2025030707445356100_r52","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1054\/bjoc.2000.1228","article-title":"Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma","volume":"83","author":"Shen","year":"2000","journal-title":"Br. J. Cancer"},{"key":"2025030707445356100_r53","doi-asserted-by":"crossref","first-page":"e8611","DOI":"10.1371\/journal.pone.0008611","article-title":"Stromal cell-derived factor-1\/CXCL12 contributes to MMTV-Wnt1 tumor growth involving Gr1+CD11b+ cells","volume":"5","author":"Liu","year":"2010","journal-title":"PLoS ONE"},{"key":"2025030707445356100_r54","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.4161\/cc.5.15.3112","article-title":"Stromal fibroblasts in cancer: a novel tumor-promoting cell type","volume":"5","author":"Orimo","year":"2006","journal-title":"Cell Cycle"},{"key":"2025030707445356100_r55","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1073\/pnas.0601807103","article-title":"Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis","volume":"103","author":"Nozawa","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030707445356100_r56","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1158\/0008-5472.CAN-04-1272","article-title":"Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer","volume":"64","author":"Curiel","year":"2004","journal-title":"Cancer Res."},{"key":"2025030707445356100_r57","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nri1785","article-title":"Neutrophils and immunity: challenges and opportunities","volume":"6","author":"Nathan","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"2025030707445356100_r58","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1189\/jlb.0311177","article-title":"Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice","volume":"91","author":"Youn","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"2025030707445356100_r59","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/sj.mt.6300215","article-title":"Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow","volume":"15","author":"Breitbach","year":"2007","journal-title":"Mol. Ther."},{"key":"2025030707445356100_r60","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/0008-5472.CAN-04-4043","article-title":"Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma","volume":"65","author":"Wei","year":"2005","journal-title":"Cancer Res."},{"key":"2025030707445356100_r61","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1634\/stemcells.2007-0461","article-title":"Vaccinia virus infection modulates the hematopoietic cell compartments in the bone marrow","volume":"26","author":"Singh","year":"2008","journal-title":"Stem Cells"},{"key":"2025030707445356100_r62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","article-title":"A CXCL1 paracrine network links cancer chemoresistance and metastasis","volume":"150","author":"Acharyya","year":"2012","journal-title":"Cell"},{"key":"2025030707445356100_r63","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1038\/nprot.2006.328","article-title":"Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients","volume":"1","author":"Shepherd","year":"2006","journal-title":"Nat. Protoc."},{"key":"2025030707445356100_r64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1099\/vir.0.82216-0","article-title":"Oral vaccination with modified vaccinia virus Ankara attached covalently to TMPEG-modified cationic liposomes overcomes pre-existing poxvirus immunity from recombinant vaccinia immunization","volume":"88","author":"Naito","year":"2007","journal-title":"J. Gen. Virol."},{"key":"2025030707445356100_r65","doi-asserted-by":"crossref","first-page":"9245","DOI":"10.1158\/0008-5472.CAN-09-2802","article-title":"Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy","volume":"69","author":"Kusumbe","year":"2009","journal-title":"Cancer Res."},{"key":"2025030707445356100_r66","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4614-1445-2_8","article-title":"Tumor dormancy and cancer stem cells: two sides of the same coin?","volume":"734","author":"Kleffel","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"2025030707445356100_r67","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrc2256","article-title":"Models, mechanisms and clinical evidence for cancer dormancy","volume":"7","author":"Aguirre-Ghiso","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"2025030707445356100_r68","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"2025030707445356100_r69","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood.V84.9.3071.3071","article-title":"WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia","volume":"84","author":"Inoue","year":"1994","journal-title":"Blood"},{"key":"2025030707445356100_r70","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2005.09.052","article-title":"Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer","volume":"101","author":"Hylander","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"2025030707445356100_r71","doi-asserted-by":"crossref","first-page":"R196","DOI":"10.1093\/hmg\/ddl196","article-title":"The many facets of the Wilms\u2019 tumour gene, WT1","volume":"15","author":"Hohenstein","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"2025030707445356100_r72","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ng.494","article-title":"Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin","volume":"42","author":"Mart\u00ednez-Estrada","year":"2010","journal-title":"Nat. Genet."},{"key":"2025030707445356100_r73","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"2025030707445356100_r74","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1158\/0008-5472.CAN-11-1400","article-title":"Cancer stem cell vaccination confers significant antitumor immunity","volume":"72","author":"Ning","year":"2012","journal-title":"Cancer Res."},{"key":"2025030707445356100_r75","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1172\/JCI6909","article-title":"Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells","volume":"104","author":"Dhodapkar","year":"1999","journal-title":"J. Clin. Invest."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/193\/10\/5327\/61494006\/1400201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/193\/10\/5327\/61494006\/1400201.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T03:16:19Z","timestamp":1741317379000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/193\/10\/5327\/7960314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":75,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,11,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1400201","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,11]]},"published":{"date-parts":[[2014,11]]}}}